Relating to income, franchise, excise, sales, and use tax provisions and affecting small business.
Submitted by the Department of Revenue.
hist162050Report received from Agency, January 31, 2023.
hist162371Referred to the committee on Universities and Revenue, February 14, 2023.
Relating to the processes for complaints and requests for advice.
Submitted by the Ethics Commission.
hist162051Report received from Agency, January 31, 2023.
hist162370Referred to the committee on Government Operations, Elections and Consumer Protection, February 14, 2023.
Relating to Wisconsin Fast Forward Workforce Training Grants.
Submitted by the Department of Workforce Development.
hist162048Report received from Agency, January 31, 2023.
hist162369Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, February 14, 2023.
Relating to qualified residential treatment programs.
Submitted by the Department of Children and Families.
hist162040Report received from Agency, January 30, 2023.
hist162368Referred to the committee on Health, February 14, 2023.
_____________
The committee on Health reported and recommended:
Relating to continuing medical education for physicians.
hist162492No action taken on February 14, 2023.
hist162493Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to telehealth.
hist162490No action taken on February 14, 2023.
hist162491Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to telehealth.
hist162488No action taken on February 14, 2023.
hist162489Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to name and address change, floor design, procedures for disciplinary proceedings, superseded references, and technical correction.
hist162486No action taken on February 14, 2023.
hist162487Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to requirements for class III permits for anesthesia.
hist162484No action taken on February 14, 2023.
hist162485Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Crotonyl Fentanyl.
hist162482No action taken on February 14, 2023.
hist162483Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Remimazolam.
hist162480No action taken on February 14, 2023.
hist162481Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to radiation protection requirements for radiation-producing machines and radioactive materials.
hist162478No action taken on February 14, 2023.
hist162479Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Brorphine.
hist162476No action taken on February 14, 2023.
hist162477Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to service fund for people who are deaf, deafblind or hard of hearing.
hist162474No action taken on February 14, 2023.
hist162475Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to long-term care services and Medical Assistance fair hearing process.
hist162472No action taken on February 14, 2023.
hist162473Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Serdexmethylphenidate.
hist162470No action taken on February 14, 2023.
hist162471Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling ten (10) fentanyl related substances.
hist162445No action taken on February 14, 2023.
hist162446Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Alfaxalone.
hist162443No action taken on February 14, 2023.
hist162444Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to Excluding 6-beta-Naltrexol.
hist162441No action taken on February 14, 2023.
hist162442Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Fospropofol.
hist162439No action taken on February 14, 2023.
hist162440Referred to the joint committee for review of Administrative Rules, February 14, 2023.
Relating to scheduling Embutramide.
hist162437No action taken on February 14, 2023.
Loading...
Loading...